Print this page Share

Medical Product Regulatory Affairs: Pharmaceuticals, Diagnostics, Medical Devices

ISBN: 978-3-527-31877-3
297 pages
September 2008, Wiley-Blackwell
Medical Product Regulatory Affairs: Pharmaceuticals, Diagnostics, Medical Devices (3527318771) cover image


Written in a clear and concise style by an experienced author, this attractively-priced book covers regulatory affairs in all major global markets for pharmaceuticals and medical devices, making it the most comprehensive in its field.
Following a look at drug development, complete sections are devoted to national and EU regulatory issues, manufacturing license application and retention, and regulation in the USA. Other topics dealt with include CDER, CBER and marketing and manufacturing licenses, the ICH process and Good Laboratory/Clinical/Manufacturing Practices.
Everything pharmacologists, bioengineers, pharma engineers, students in pharmacy and those working in the pharmaceutical industry need to know about medical regulatory affairs.
See More

Table of Contents

What is a drug, and what is a device? Basic principles and definitions of healthcare products
The regulatory framework: FDA, EMEA, other regulatory authorities
The drug development process: pre-clinical and clinical studies
Medical devices: design control, validation, risk management
Regulatory submissions: forms and requirements
Quality systems: GMP, ISO norms, software validation
Post-marketing issues: surveillance, corrective and preventive actions
World harmonization of regulatory requirements
See More

Author Information

J.J. Tobin worked for many years and in various capacities within Olympus diagnostica GmbH, a company employing several 100 people who develop and manufacture in vitro diagnostic reagents. Dr. Tobin therefore has extensive experience of working within an FDA and European medical device regulatory framework.

Gary Walsh is a senior lecturer in industrial biochemistry at the University of Limerick, Ireland. He has direct industrial experience within the pharmaceutical industry, as well as extensive teaching and non-laboratory based research interests in the pharmaceutical biotechnology arena. He has published a number of books, book chapters and journal articles relevant to this publication. He also teaches elements of pharmaceutical science and regulatory affairs on an annual course provided by the University of Limerick to an international medical device company with a manufactoring facility based in the region.
See More


"This book is an excellent reference for people starting out in regulatory affairs, as well as those working within the area whose product portfolio is adapting and changing." (Microbiology Today, May 2009)
See More

Buy Both and Save 25%!


Medical Product Regulatory Affairs: Pharmaceuticals, Diagnostics, Medical Devices (US $131.95)

-and- Pharmaceutical Biotechnology: Concepts and Applications (US $100.95)

Total List Price: US $232.90
Discounted Price: US $174.67 (Save: US $58.23)

Buy Both
Cannot be combined with any other offers. Learn more.

Related Titles

Back to Top